miRNA-221 is one of the over 700 kinds of currently known microRNAs (miRNAs) and is up-regulated in multiple tumors, suggesting that it may be a potential carcinogenic miRNA. Few studies have explored the relationship between miRNA-221 and hepatocellular carcinoma (HCC). We performed real-time quantitative polymerase chain reaction (qPCR) to detect miRNA-221 expression in HCC and para-carcinoma tissues and to explore the relationship between abnormal expression of miRNA-221 and clinicopathological features of HCC patients. miRNA-221 expression was significantly higher in HCC tissues than in adjacent tissues (P < 0.001). We analyzed the relationship between miRNA-221 expression level and clinicopathological characteristics of HCC patients. Our results suggested that miRNA-221 expression level was closely related to tumor stage (P = 0.012), number of tumor nodes (P = 0.018), and microvascular invasion (P = 0.010) in HCC patients. The results of survival analysis suggested that HCC patients with up-regulated miRNA-221 expression had a shorter survival time. The high miRNA-221 expression indicates the poor prognosis of HCC patients; thus, miRNA-221 can be regarded an important molecular marker for HCC prognosis.
TorreLA, BrayF, SiegelRL, FerlayJ, Lortet-TieulentJ, JemalA. Global cancer statistics, 2012. CA Cancer J Clin. 2015, 65(2): 87-108. doi: 10.3322/caac.21262.
2.
ChienYC, JanCF, ChiangCJ, KuoHS, YouSL, ChenCJ. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees. Hepatology. 2014, 60(1): 125-32. doi: 10.1002/hep.27048.
3.
HayesCN, ChayamaK. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int J Mol Sci. 2016, 17(3): 280. doi: 10.3390/ijms17030280.
4.
TomasettiM, SantarelliL, NeuzilJ, DongL. MicroRNA regulation of cancer metabolism: role in tumour suppression. Mitochondrion. 2014, 19: 29-38. doi: 10.1016/j.mito.2014.06.004.
5.
BoyeA, YangY. Hepatic microRNA orchestra: a new diagnostic, prognostic and theranostic tool for hepatocarcinogenesis. Mini Rev Med Chem. 2014, 14(10): 837-52.
LivakKJ, SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25(4): 402-8. doi: 10.1006/meth.2001.1262.
9.
SongY, WangF, HuangQ, CaoY, ZhaoY, YangC. MicroRNAs Contribute to Hepatocellular Carcinoma. Mini Rev Med Chem. 2015, 15(6): 459-66.
10.
LandiD, GemignaniF, LandiS. Role of variations within microRNA-binding sites in cancer. Mutagenesis. 2012, 27(2): 205-10. doi: 10.1093/mutage/ger055.
11.
VincentK, PichlerM, LeeGW, LingH. MicroRNAs, genomic instability and cancer. Int J Mol Sci. 2014, 15(8): 14475-91. doi: 10.3390/ijms150814475.
12.
GanciF, VicoC, KoritaE, et al. MicroRNA expression profiling of thymic epithelial tumors. Lung Cancer. 2014, 85(2): 197-204. doi: 10.1016/j.lungcan.2014.04.008.
13.
AdamsBD, KasinskiAL, SlackFJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014, 24(16): 762-76. doi: 10.1016/j.cub.2014.06.043.
14.
VenturaA, JacksT. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009, 136(4): 586-91. doi: 10.1016/j.cell.2009.02.005.
15.
PngKJ, HalbergN, YoshidaM, TavazoieSF. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature. 2011, 481(7380): 190-4. doi: 10.1038/nature10661.
16.
BakhshandehB, HafiziM, GhaemiN, SoleimaniM. Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells. Biotechnol Lett. 2012, 34(8): 1579-87. doi: 10.1007/s10529-012-0934-3.
17.
KoelzM, LenseJ, WrbaF, SchefflerM, DienesHP, OdenthalM. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors. Int J Oncol. 2011, 38(2): 503-11. doi: 10.3892/ijo.2010.857.
18.
LorimerIA. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle. 2009, 8(17): 2685. doi: 10.4161/cc.8.17.9489.
19.
TetzlaffMT, LiuA, XuX, et al. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol. 2007, 18(3): 163-73. doi: 10.1007/s12022-007-0023-7.
20.
GanR, YangY, YangX, ZhaoL, LuJ, MengQH. Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3. Cancer Gene Ther. 2014, 21(7): 290-6. doi: 10.1038/cgt.2014.29.
21.
LvJ, XuL, XuY, et al. Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis. Zhongguo Fei Ai Za Zhi. 2014, 17(3): 221-5.
22.
IhleMA, TrautmannM, KuenstlingerH, et al. miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours. Mol Oncol. 2015, 9(7): 1421-33. doi: 10.1016/j.molonc.2015.03.013.
23.
XuY, ZhongC, DingS, HuangH, ShenZ. MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth. Int J Clin Exp Med. 2015, 8(2): 2024-30.
24.
AcibucuF, DökmetaHS, TutarY, ElagozS, KilicliF. Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers. Exp Clin Endocrinol Diabetes. 2014, 122(3): 137-43. doi: 10.1055/s-0034-1367025.
25.
LuQ, LuC, ZhouGP, ZhangW, XiaoH, WangXR. MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL. Urol Oncol. 2010, 28(6): 635-41. doi: 10.1016/j.urolonc.2009.06.005.
26.
ChenD, YanW, LiuZ, et al. Downregulation of miR-221 enhances the sensitivity of human oral squamous cell carcinoma cells to Adriamycin through upregulation of TIMP3 expression. Biomed Pharmacother. 2016, 77: 72-8. doi: 10.1016/j.biopha.2015.12.002.
27.
ZhouY, YangQ, XuH, et al. miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway. PLoS One. 2016, 11(2): e0148821. doi: 10.1371/journal.pone.0148821.
28.
LeeJ, ChoiKJ, MoonSU, KimS. Theragnosis-based combined cancer therapy using doxorubicin-conjugated microRNA-221 molecular beacon. Biomaterials. 2016, 74: 109-18. doi: 10.1016/j.biomaterials.2015.09.036.
